drugset / Trial / NCT02632630
Nutrition Supplementation in Hospitalized Patients
Phase 2
Completed
100 enrolled
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Academic Medical Organization of Southwestern Ontario · collab
RandomizedFactorialOpen-labelTreatment
Summary
Patients with severe malnutrition risk are 7.4 times more likely to die in hospital than well-nourished patients, and carry a 30-day readmission rate of \>46%. Although malnutrition is common and is associated with extremely poor outcomes, it is neglected and undertreated. This is a randomized controlled pilot trial to rapidly identify at-risk hospitalized medical patients, and then provide nutritional supplementation in hospital and after discharge for 28 days. In select at-risk patients, 5 days of nutrition delivered through a peripheral vein will be used in addition to oral nutritional supplementation.
Timeline
- Start
- 2016-03
- Primary completion
- 2018-02
- Completion
- 2018-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dextrose | Unknown | — | Intravenous |
| Comparator | Peri-OLIMEL 2.5% E | Unknown | — | Intravenous |
| Comparator | Ringer's Lactate | Other / unclassified | — | Intravenous |
| Comparator | sodium chloride | Unknown | — | Intravenous |